Duration: (3:31) ?Subscribe5835 2025-02-08T03:54:02+00:00
The efficacy of psychodynamic psychotherapy EN
(2:21)
“Bet hedging” explains the efficacy of many combination cancer therapies
(2:13)
Culture Shock - Questioning the Efficacy and Safety of Probiotics
(4:48)
Evaluating the Efficacy of Herbs and Supplements
(1:25:46)
Dr. Keith Stewart Discusses the Efficacy of Carfilzomib in the ASPIRE Trial
(47)
The Doctor Is In: Scott Atlas and the Efficacy of Lockdowns, Social Distancing, and Closings
(50:31)
The Efficacy and Safety of Creatine for High Homocysteine
(7:9)
Can the efficacy of one drug be influenced by another?
(1:24)
The latest advancements in disease-modifying therapies for myelofibrosis
(2:24)
The Efficacy, Safety, and Side Effects of Botox and Facelifts
(5:7)
Discussing the Efficacy of Alemtuzumab
(5:10)
THE EFFICACY OF THE BLOOD BY GBILE AKANNI
(1:6:47)
Trump Talks Tariffs, Trade and US Steel at US-Japan News Conference
(3:57)
8 Powerful Ways to Use Holy Water \u0026 Its Efficacy
(12:57)
My MS Story - A Paediatric Diagnosis
(22:30)
The Top Five Side Effects of a High Homocysteine Level
(2:31)
Should Vegetarians Take Creatine to Normalize Homocysteine?
(5:3)
The Efficacy and Side Effects of Moringa Leaf Powder
(5:42)
The Best Diet for Weight Loss and Disease Prevention
(5:27)
Dr. Michael Greger | Soy, Gas, Water, Fasting, Hair Loss, Nuts Raw or Roasted? etc.
(33:48)
Cyclophosphamide Mnemonic for NCLEX | Nursing Pharmacology
(6:7)
Optimizing the efficacy of T-cell based immunotherapies
(1:48)
Insights into the REVEAL trial: the efficacy of ruxolitinib for the treatment of patients with PV
(1:27)
Dr. Mesa on the Efficacy of Fedratinib in Patients With Myelofibrosis and Low Platelet Counts
Ongoing trials investigating the efficacy of pirtobrutinib in CLL
(2:14)
Results of Phase II trial to assess the efficacy and safety of idelalisib
(4:4)
The efficacy of low-dose ASTX727 in low-risk MDS
(4:11)
Evaluating the efficacy of ixazomib, cyclophosphamide and dexamethasone in amyloidosis
(1:26)
Dr. Levy on the Efficacy of Crizotinib Versus Entrectinib in ROS1+ Lung Cancer
(2:3)
Assessing the efficacy of antibodies targeting α-synuclein
(1:38)